Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study

Fig. 1

Kaplan-Meier analysis of (a) overall and (b) relapse-free survival of patients who were treated with tegafur-uracil for LVI-positive stage IA NSCLC in adjuvant setting. Kaplan-Meier analysis of (c) overall and (d) relapse-free survival of patients who were treated with tegafur-uracil for 2 cm or less size LVI-positive stage IA NSCLC in adjuvant setting. LVI, lymphovascular invasion; NSCLC, non-small cell carcinoma

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us

\